Reading CORT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CORT free→Reading CORT? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CORT free→QuarterlyIQ Insights · CORT
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Other Events. On May 19, 2026, Corcept Therapeutics Incorporated (the “Company”) learned that the United States Department of Justice (the “DOJ”) had filed a Notice of Election to Decline Intervention (the “Notice”) in a civil qui tam action filed against the company, captioned U.S. et al. ex rel. Stephen Elliott v. Corcept Therapeutics, Inc. , No. 17-CV-1303 (SRC) (D.N.J.). That action was initiated in February 2017, in the District Court of New Jersey, by a former employee of the Company (t…
The filing is about the approval of an amendment to a compensation plan, not a management change.
Results of Operations and Financial Condition.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.